| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 679937 | 56232 | TEGRETOL 400 mg COMPRIMIDOS | TEGRETOL 400 mg COMPRIMIDOS , 100 comprimidos | 400 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56232/56232_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56232/56232_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1983-08-01 | 1 | 1 | 1 | 1983-08-01 | 2011-04-28 | 1 | 2012-05-25 | View Edit Delete | ||||||||||||
| 679945 | 39955 | TEGRETOL 200 mg COMPRIMIDOS | TEGRETOL 200 mg COMPRIMIDOS, 50 comprimidos | 200 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39955/39955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39955/39955_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1964-07-01 | 1 | 1 | 1 | 1964-07-01 | 2011-04-28 | 1 | 2012-05-25 | View Edit Delete | ||||||||||||
| 679946 | 39955 | TEGRETOL 200 mg COMPRIMIDOS | TEGRETOL 200 mg COMPRIMIDOS, 100 comprimidos | 200 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39955/39955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39955/39955_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1964-07-01 | 1 | 1 | 1 | 1964-07-01 | 2011-04-28 | 1 | 2012-05-25 | View Edit Delete | ||||||||||||
| 677331 | 73770 | ABRION 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ABRION 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 1 comprimido | 150 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73770/73770_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73770/73770_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2011-03-30 | 1 | 1 | 1 | 2011-03-30 | 2011-03-30 | 1 | 2012-10-14 | View Edit Delete | ||||||||||||
| 677332 | 73770 | ABRION 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ABRION 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 3 comprimidos | 150 mg | 5 | 3 | 10 | 3 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73770/73770_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73770/73770_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2011-03-30 | 1 | 1 | 1 | 2011-03-30 | 2011-03-30 | 1 | 2012-10-14 | View Edit Delete | ||||||||||||
| 678888 | 61134 | CRONODINE 240 mg CAPSULAS DE LIBERACION PROLONGADA | CRONODINE 240 mg CAPSULAS DE LIBERACION PROLONGADA , 30 cápsulas | 240 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61134/61134_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61134/61134_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-04 | View Edit Delete | ||||||||||||
| 678896 | 61133 | TRUMSAL 180 mg CAPSULAS DE LIBERACION PROLONGADA | TRUMSAL 180 mg CAPSULAS DE LIBERACION PROLONGADA , 30 cápsulas | 180 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61133/61133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61133/61133_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-04 | View Edit Delete | ||||||||||||
| 678904 | 61132 | CRONODINE 120 mg CAPSULAS DE LIBERACION PROLONGADA | CRONODINE 120 mg CAPSULAS DE LIBERACION PROLONGADA , 30 cápsulas | 120 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61132/61132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61132/61132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-04 | View Edit Delete | ||||||||||||
| 677306 | 73273 | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73273/73273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73273/73273_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-10 | 1 | 1 | 1 | 2025-04-14 | 2025-04-14 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 677308 | 73322 | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG, 30 cápsulas | 1,5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73322/73322_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73322/73322_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 677311 | 73321 | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73321/73321_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73321/73321_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 677413 | 73340 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 300 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73340/73340_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73340/73340_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677414 | 73341 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 150 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73341/73341_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73341/73341_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677415 | 73342 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 300 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73342/73342_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73342/73342_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677479 | 68071 | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos | 40 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68071/68071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68071/68071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2011-02-02 | 1 | 2015-07-21 | View Edit Delete | ||||||||||||
| 677480 | 68071 | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68071/68071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68071/68071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2011-02-02 | 1 | 2014-08-09 | View Edit Delete | ||||||||||||
| 677561 | 73494 | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 320 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73494/73494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73494/73494_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-02-10 | 1 | 1 | 1 | 2011-02-10 | 2011-02-10 | 1 | 2011-05-17 | View Edit Delete | ||||||||||||
| 677562 | 73493 | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/12.5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/12.5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 320 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73493/73493_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73493/73493_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-02-10 | 1 | 1 | 1 | 2011-02-10 | 2011-02-10 | 1 | 2011-05-17 | View Edit Delete | ||||||||||||
| 677580 | 73538 | LANSOPRAZOL KERN PHARMA 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL KERN PHARMA 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (BLISTER) | 15 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73538/73538_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73538/73538_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-02-16 | 1 | 1 | 1 | 2011-02-16 | 2011-02-16 | 1 | 2013-10-21 | View Edit Delete | ||||||||||||
| 677581 | 73537 | LANSOPRAZOL KERN PHARMA 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL KERN PHARMA 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas (BLISTER) | 30 mg | 5 | 28 | 43 | 28 cápsulas (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73537/73537_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73537/73537_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-02-16 | 1 | 1 | 1 | 2011-02-16 | 2011-02-16 | 1 | 2013-10-21 | View Edit Delete |
Page 275 of 1036, showing 20 records out of 20716 total, starting on record 5481, ending on 5500